BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6310958)

  • 1. Characterization of mechanical effects and beta-adrenoceptor binding of prenalterol in rat myocardium.
    Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):3-11. PubMed ID: 6310958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of functional influence by prenalterol through alpha 1-adrenoceptors in rat myocardium.
    Aass H; Hedberg A; Skomedal T; Carlsson E; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Jul; 53(1):12-5. PubMed ID: 6310957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo treatment with isoprenaline or prenalterol on beta-adrenoceptor mechanisms in the heart and soleus muscle of the cat.
    Hedberg A; Mattsson H; Nerme V; Carlsson E
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):251-8. PubMed ID: 6145101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The measurement of the relative efficacy of agonists by selective potentiation of tissue responses: studies with isoprenaline and prenalterol in cardiac tissue.
    Kenakin TP; Beek D
    J Auton Pharmacol; 1984 Sep; 4(3):153-9. PubMed ID: 6208197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.
    Hedberg A; Carlsson E; Fellenius E; Lundgren B
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):185-91. PubMed ID: 6121296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of a pronounced preference of prenalterol for the beta-l-adrenoceptor subtype.
    Rohm N; Wagner J; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(1):85-8. PubMed ID: 6113550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trifluoperazine on beta-adrenergic responses of rat papillary muscle: related to calmodulin?
    Aass H; Skomedal T; Osnes JB
    Acta Pharmacol Toxicol (Copenh); 1983 Oct; 53(4):265-74. PubMed ID: 6139931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H; Andersson T; Carlsson E; Hedberg A; Lundgren B; Olsson T
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):302-8. PubMed ID: 6132344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta 1-Adrenoceptors mediating relaxation of the guinea-pig trachea: experiments with prenalterol, a beta 1-selective adrenoceptor agonist.
    Johansson U; Waldeck B
    J Pharm Pharmacol; 1981 Jun; 33(6):353-6. PubMed ID: 6115005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of forskolin and isoprenaline on tracheal, cardiac and skeletal muscles from guinea-pig.
    Waldeck B; Widmark E
    Eur J Pharmacol; 1985 Jun; 112(3):349-53. PubMed ID: 4040470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of prenalterol for adrenergic receptor subtypes: a potential mechanism of inotropic selectivity.
    Williams RS
    J Cardiovasc Pharmacol; 1983; 5(2):266-71. PubMed ID: 6188901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenalterol is an agonist at beta 2- as well as at beta 1-adrenoceptors.
    Apperley GH; Drew GM; Sullivan AT
    Eur J Pharmacol; 1982 Jul; 81(4):659-63. PubMed ID: 6126381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Actions of prenalterol, a new cardioselective beta1-agonist, terbutaline and isoprenaline on electrophysiological and mechanical parameters of guinea pig atrial and papillary muscles.
    Arlock P
    Acta Pharmacol Toxicol (Copenh); 1982 Jul; 51(1):12-9. PubMed ID: 6126991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on mechanisms for beta-adrenoceptor mediated inhibition of colon motility.
    Ek B
    Acta Physiol Scand Suppl; 1985; 546():1-39. PubMed ID: 2869641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of molecular structure on the affinity and efficacy of some beta-adrenoceptor agonists.
    Molenaar P; McPherson GA; Malta E; Raper C
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):240-6. PubMed ID: 2868416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity constants and beta-adrenoceptor reserves for isoprenaline on cardiac tissue from normotensive and hypertensive rats.
    Doggrell SA; Petcu EB; Barnett CW
    J Pharm Pharmacol; 1998 Feb; 50(2):215-23. PubMed ID: 9530991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.
    Juberg EN; Minneman KP; Abel PW
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):193-202. PubMed ID: 2865685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.